“The revised outlook reflects our view of BDCH’s softening profitability and coverage levels in fiscal year 2016 and year-to-date fiscal 2017 that represent a departure from a multi-year strengthening trend for related financial metrics which had been a key factor supporting the positive outlook,” said S&P Global Ratings credit analyst Wendy Towber. “The stable outlook further reflects our view of BDCH’s modest growth in unrestricted reserves, growing outpatient presence in its limited service area and strategic initiatives around physicians and access to care.”
S&P also affirmed the “BBB-” rating on BDCH’s series 2013A fixed rate revenue bonds.
More articles on healthcare finance:
Moody’s affirms The Christ Hospital’s ‘A3’ rating
Moody’s affirms DCH Health System’s ‘A2’ rating
Moody’s affirms Aurora Health Care’s ‘A2’ rating
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
